What an anesthesiologist should know about pediatric arrhythmias

Area of Science:

• Pediatric Anesthesiology
• Cardiology
• Pharmacology

Background:

• Pediatric arrhythmias, including narrow and wide complex tachycardias, pose risks during anesthesia, especially in patients with channelopathies or cardiomyopathies.
• Many pediatric patients lack baseline ECGs, making intraoperative arrhythmia identification crucial.
• Common triggers include intubation and surgical stimulation.

Purpose of the Study:

• To review key anesthetic considerations for pediatric arrhythmias.
• To highlight the importance of recognizing and managing supraventricular and ventricular tachycardias in pediatric patients under general anesthesia.
• To discuss pharmacological treatments and risks associated with inherited arrhythmia syndromes.

Main Methods:

• Review of common pediatric tachycardias: supraventricular tachycardia (SVT) and ventricular arrhythmias.
• Discussion of specific conditions: Wolff-Parkinson-White syndrome, congenital long QT syndrome, and catecholaminergic polymorphic ventricular tachycardia.
• Analysis of anesthetic implications, including triggers, diagnostic challenges, and therapeutic strategies.

Main Results:

• Supraventricular tachycardia is the most common pediatric tachyarrhythmia, often treated with adenosine.
• Reentrant tachycardias (AVRT, AVNRT) and automatic tachycardias (AT, JET) are frequent.
• Ventricular arrhythmias like Torsades de Pointes and ventricular fibrillation are associated with inherited syndromes and can be exacerbated by QT-prolonging medications.

Conclusions:

• Anesthesiologists must be prepared to manage pediatric arrhythmias, recognizing triggers and appropriate acute therapies like adenosine.
• Non-selective beta-blockers are crucial for managing long QT syndrome and catecholaminergic polymorphic ventricular tachycardia.
• Careful medication selection is vital to avoid exacerbating QT interval prolongation and arrhythmia risk.